What Outlook Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 4 | 10 |
| Sells | 0 | 0 |
| Total trades | 4 | 10 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 5,493,825 | 23,753,591 |
| Disposed | 0 | 0 |
| Net activity | +5,493,825 | +23,753,591 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Jahr Robert Charles | Chief Executive Officer | Aug 14 | Open-market buy · P | +151,515 | — | — | 151,515 |
| Kenyon Lawrence A | Chief Financial Officer | Aug 14 | Open-market buy · P | +101,010 | — | — | 106,956 |
| Sukhtian Ghiath M. | Director | Aug 12 | Open-market buy · P | +2,525,252 | $0.99 | +$2.5M | 24,617,320 |
| Sukhtian Faisal Ghiath | Director | Jul 29 | Open-market buy · P | +95,398 | $1.05 | +$100K | 220,972 |
| Haddadin Yezan Munther | Director | Jun 02 | Open-market buy · P | +29,000 | $0.83 | +$24.1K | 66,167 |
| Sukhtian Ghiath M. | Director | May 28 | Open-market buy · P | +8,539,709 | $0.59 | +$5M | 22,092,068 |
| Sukhtian Faisal Ghiath | Director | May 27 | Open-market buy · P | +122,174 | $0.41 | +$50K | 125,574 |
| Thurman Randy H | Director | May 26 | Open-market buy · P | +5,000 | $0.43 | +$2.15K | 5,593 |
| Haddadin Yezan Munther | Director | May 26 | Open-market buy · P | +34,000 | $0.44 | +$15K | 37,167 |
| Hilzinger Kurt J | Director | May 26 | Open-market buy · P | +400,000 | $0.44 | +$177K | 423,655 |
| Sukhtian Ghiath M. | Director | May 27 | Grant / award · A | +4,285,714 | $1.40 | +$6M | 13,552,359 |
| Sukhtian Ghiath M. | Director | Jan 17 | Exercise / conversion · M | +3,458,571 | $2.51 | +$8.68M | 9,266,645 |
| Kenyon Lawrence A | Chief Financial Officer | Sep 26 | Open-market buy · P | +5,000 | $5.69 | +$28.4K | 5,946 |
| Syntone Ventures Llc | 10% owner | Apr 15 | Open-market buy · P | +714,286 | — | — | 1,705,438 |
| Haddadin Yezan Munther | Director | Mar 28 | Open-market buy · P | +1,882 | $11.82 | +$22.2K | 5,049 |
| Sukhtian Ghiath M. | Director | Mar 18 | Grant / award · A | +2,305,714 | — | — | 5,808,074 |
| Evanson Jeff | CHIEF COMMERCIAL OFFICER | Mar 07 | Open-market buy · P | +62,484 | $0.42 | +$26.2K | 808,459 |
| Dagnon Terry | Chief Operations Officer | Apr 20 | Sale for tax withholding · S | −520,000 | $1.14 | −$590K | 653,058 |
| Evanson Jeff | Chief Commercial Officer | Jan 20 | Sale for tax withholding · S | −267,000 | $1.11 | −$296K | 745,975 |
| Evanson Jeff | Chief Commercial Officer | Jan 19 | Sale for tax withholding · S | −103,255 | $1.22 | −$126K | 1,012,975 |
Loading...
